A Quick Look at Today's Ratings for OptimizeRx(OPRX.US), With a Forecast Between $12.5 to $22
OptimizeRx | 10-Q: Quarterly report
OptimizeRx Price Target Raised to $12.50/Share From $8.00 by Stifel
OptimizeRx Is Maintained at Buy by Stifel
$OPRX Stock Is up 18% Today. Here's What We See in Our Data.
JMP Securities Maintains Market Outperform on OptimizeRx, Raises Price Target to $14
OptimizeRx Analyst Ratings
Express News | OptimizeRx Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Financial Results and Raised Its FY25 Sales Guidance With Its Midpoint Above Estimates
B. Riley Adjusts Price Target on OptimizeRx to $18 From $13, Maintains Buy Rating
Q1 2025 OptimizeRx Corp Earnings Call
Market-Moving News for May 13th
Lake Street Maintains OptimizeRx(OPRX.US) With Buy Rating, Maintains Target Price $11
William Blair Maintains OptimizeRx(OPRX.US) With Buy Rating
Roth MKM Maintains OptimizeRx(OPRX.US) With Buy Rating, Raises Target Price to $22
OptimizeRx (OPRX) Gets a Buy From Roth MKM
OptimizeRx: Strong Financial Performance and Strategic Growth Positioning for Potential Acquisition
OptimizeRx Corp. (OPRX) Beats Q1 Earnings and Revenue Estimates
12 Health Care Stocks Moving In Monday's After-Market Session
OptimizeRx Reports Q1 Non-GAAP EPS 8c, Consensus (12c)
OptimizeRx Updates Fiscal Yr 2025 Guidance